69 Best Biopharmaceutical Startups to Watch in 2024

RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.

Total Raised: $1018.00M

Last Funding: $1000.00M (Series D)

RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.

Total Raised: $1000.00M

Last Funding: $1000.00M (Series D)

Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes

Total Raised: $313.00M

Last Funding: $18.00M (Unknown)

Oral antifungal therapy developer to treat life-threatening rare fungal infections

Total Raised: $170.00M

Last Funding: $100.00M (Series D)

Digital health platform for predictive care and research.

Total Raised: $235.00M

Last Funding: $80.00M (Series D)

SparingVision is a retinal Gene Therapy Treatments founded by Jose alain sahel.

Total Raised: $52.81M

Last Funding: $52.81M (Series A)

Immatics Biotechnologies is a biopharmaceutical company focused on the discovery and development of immunotherapy of cancer.

Total Raised: $180.09M

Last Funding: $58.00M (Series E)

A company developing therapeutics for acute inflammatory central nervous system conditions

Total Raised: $24.30M

Last Funding: $6.50M (Series F)

InfalRX is a Germany-based company.

Total Raised: $55.00M

Last Funding: $55.00M (Series D)

Small Molecules based on Omega-3 Fatty acid metabolites

Total Raised: $34.90M

Last Funding: $19.40M (Series C)

Abalos Therapeutics is a viral Immuno-Oncology Treatment founded in 2005.

Total Raised: $43.00M

Last Funding: $43.00M (Series A)

Hifibio - High Fidelity Biology is a single cell technologies for drug discovery founded in 2013 by Liang Schweizer, Jeff He and Robert Nicol.

Total Raised: $75.00M

Last Funding: $75.00M (Series D)

Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.

Total Raised: $88.00M

Last Funding: $88.00M (Series D)

GeneQuine Biotherapeutics GmbH is a German based biotechnology company that was founded in 2011

Total Raised: $9.88M

Last Funding: $3.37M (Unknown)

German company is a provider of targeted drug rescue program intended to involve pharmaceutical research and development.

Total Raised: $10.00M

Last Funding: $10.00M (Series A)

Brainvectis is a biotechnology company developing treatments for neurodegenerative diseases through restoring cholesterol metabolism in the brain.

Total Raised: $1.20M

Last Funding: $1.20M (Series A)

Asklepios Biopharmaceutical is a company in North Carolina.

Total Raised: $1.60M

Last Funding: $1.60M (Unknown)

RootPath is a biotechnology company that builds powerful personalized T cell therapy platform.

Magnolia Neurosciences is a Seattle-based company founded in 2018.

Integra Holdings is a company founded in 2012.

Small Molecules based on Omega-3 Fatty acid metabolites

BioNTech is a German company that develops immunotherapies for the treatment of cancer and other diseases.

GVK Biosciences is a contract Research founded in 2001.

AveXis, Inc is now called Novartis Gene Therapies, it is a company that is committed to developing and commercializing gene therapies.

Hui-Gene Therapeutics is a company founded in 2018 by Xuan Yao.

Engine Biosciences is a San Francisco-based AI company that is focused on drugs development.

Hetero Health Care is a company founded in 1993 by Hetero Healthcare Limited.

Rgenix is a cancer treatment company founded in 2010 by Shahram Seyedin-Noor, Saeed Tavazoie, Masoud Tavazoie and Sohail Tavazoie.

Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.

Passage Bio, Inc is a Philadelphia-based biotechnology company developing genetics-based medicines.

Aro Biotherapeutics is a protein Scaffolds founded in 2018.

Lava Therapeutics is a biotechnology research company developing bispecific gamma-delta T cell engaging (bsTCE) antibodies to fight cancer.

D3 Bio is a Pudong-based company founded in 2020.

GB SCIENCES INC is a Las Vegas-based biopharmaceutical company.

Cellworks is a life sciences technology company involved in drug and bio-marker discovery and researches in therapeutic areas.

A biotechnology company focused on the discovery and development of novel drugs for cancer treatments.

A drug discovery and development company focused on immunotherapeutic agents to treat cancer, viral infections and autoimmune diseases

Fog Pharmaceuticals is a cell-penetrating miniproteins.

ApoGen Biotechnologies is focused on the development of new class of therapeutics targeting drivers of cancer genomic mutation.

Imvax is a clinical-stage biotechnology company focused on the development of patient-specific vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers with unmet medical needs.

Tesaro is a biopharmaceutical company focused on identifying cancer therapies, acquired by GSK in 2019.

Gracell Biotechnology is a developer of cancer immune therapies designed to treat cancer.

Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases

Hangzhou Just Biotherapeutics is an Hangzhou-based company founded in 2015.

Leader in delivering real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.

BenevolentAI is a bioinformatics company that develops and applies artificial intelligence and machine learning technology to analyze scientific data in order to create human health and bioscience applications.

Secura Bio is an acquisition & Worldwide Commercialization founded in 2019.

Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics.

ethris GmbH is a MRNA-based therapies founded in 2009.

Asklepios Biopharmaceutical is a company in North Carolina.

Akouos is a Brookline, Massachusetts-based biotechnology company developing precision genetics-based medicines founded in 2016 by Emmanuel Simons.

Carisma Therapeutics is a biotechnology company founded in 2016 to bring the potheyr of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).

Cytena is a biotechnology company and developer of a single-cell printing technology designed to assist contact-free deposition of single cells encapsulated in micro-droplets.

Exosome Cosmeceuticals & Biopharmaceuticals

Oncimmune is a Nottingham-based diagnostic company developing early cancer detection products.

VieCure built an engine to turn data into knowledge and take the world’s best thinking to clinicians and patients in real time.

Arbor Technologies is a company in Cambridge, MA, focusing on biodiscovery using machine learning, genome sequencing, gene synthesis and high-throughput screening.

A genetic medicines company in Massachusetts that focuses on patients suffering from rare genetic diseases.

Vaccitech is a T cell immunotherapy company developing products to treat and prevent infectious disease and cancer

Click Therapeutics, Inc. is a company founded in 2012.

BioAge Labs focuses on developing AI and systems biology-based solutions for slowing the aging process and treating age-related illnesses.